Altered MICOS Morphology and Mitochondrial Ion Homeostasis Contribute to Poly(GR) Toxicity Associated with C9-ALS/FTD

Shuangxi Li1, Zhihao Wu1, Yu Li1

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Cell Reports
|August 7, 2020
PubMed

Insights

Poly(GR) from C9ORF72 repeat expansions enters mitochondria in ALS, disrupting the MICOS complex and causing muscle damage. Restoring mitochondrial ion balance offers a potential therapeutic strategy for C9-ALS/FTD.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) involves motor neuron and other cell type pathology.
  • C9ORF72 repeat expansion is a common genetic cause of ALS and frontotemporal dementia (C9-ALS/FTD).
  • Poly(GR) peptides encoded by the repeat expansion are implicated in disease pathogenesis.

Purpose of the Study:

  • Investigate the role of poly(GR) in cellular pathology beyond motor neurons.
  • Elucidate the molecular mechanisms by which poly(GR) affects cellular function.
  • Identify potential therapeutic targets for C9-ALS/FTD.

Main Methods:

  • Utilized Drosophila muscle and patient-derived fibroblasts as model systems.
  • Examined the interaction of poly(GR) with mitochondrial components, specifically the MICOS complex.
  • Assessed mitochondrial structure, function, metabolism, and muscle integrity.
  • Tested genetic and pharmacological interventions to rescue pathology.

Main Results:

  • Poly(GR) enters mitochondria and disrupts the MICOS complex, altering its dynamics and interactions.
  • Mitochondrial inner membrane structure, ion homeostasis, and metabolism are impaired.
  • Muscle integrity is compromised in Drosophila models.
  • Similar mitochondrial defects are observed in patient fibroblasts.
  • Genetic modulation of MICOS and nigericin treatment rescued mitochondrial pathology and disease phenotypes.

Conclusions:

  • Poly(GR)-induced mitochondrial dysfunction is a key pathogenic mechanism in C9-ALS/FTD.
  • MICOS-regulated ion homeostasis is critical in C9-ALS pathogenesis.
  • Targeting mitochondrial ion homeostasis presents a promising therapeutic avenue for C9-ALS/FTD.